| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 7740 | 2017 |
| Atrial fibrillation and arterial hypertension MS Kallistratos, LE Poulimenos, AJ Manolis Pharmacological research 128, 322-326, 2018 | 119 | 2018 |
| Sympathetic overactivity in hypertension and cardiovascular disease M AJ, P LE, K MS Current vascular pharmacology 12 (1), 4-15, 2014 | 117 | 2014 |
| Blood pressure control and cardiovascular risk reduction G Antonakoudis, I Poulimenos, K Kifnidis, C Zouras, H Antonakoudis Hippokratia 11 (3), 114, 2007 | 114 | 2007 |
| Manual of hypertension of the European Society of Hypertension G Mancia, G Grassi Crc Press, 2014 | 102 | 2014 |
| The esc-eorp euro-endo (european infective endocarditis) registry G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ... European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 202-207, 2019 | 77 | 2019 |
| Medical treatment of stable angina: a tailored therapeutic approach AJ Manolis, LE Poulimenos, G Ambrosio, MS Kallistratos, ... International Journal of Cardiology 220, 445-453, 2016 | 50 | 2016 |
| The unappreciated importance of blood pressure in recent and older atrial fibrillation trials A Manolis, M Doumas, L Poulimenos, M Kallistratos, G Mancia Journal of Hypertension 31 (11), 2109-2117, 2013 | 37 | 2013 |
| Cardiac rehabilitation effects on quality of life in patients after acute myocardial infarction H Antonakoudis, K Kifnidis, A Andreadis, E Fluda, Z Konti, N Papagianis, ... Hippokratia 10 (4), 176, 2006 | 35 | 2006 |
| Trimetazidine in the prevention of tissue ischemic conditions MS Kallistratos, LE Poulimenos, S Giannitsi, P Tsinivizov, AJ Manolis Angiology 70 (4), 291-298, 2019 | 32 | 2019 |
| The J-curve in arterial hypertension: fact or fallacy? EP Tsika, LE Poulimenos, KD Boudoulas, AJ Manolis Cardiology 129 (2), 126-135, 2014 | 31 | 2014 |
| Prognostic significance of blood pressure response to exercise in patients with systolic heart failure MS Kallistratos, LE Poulimenos, AN Pavlidis, A Dritsas, ID Laoutaris, ... Heart and vessels 27, 46-52, 2012 | 30 | 2012 |
| [Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID‑19 pandemic S Giannitsi, P Tsinivizov, LE Poulimenos, MS Kallistratos, D Varvarousis, ... Experimental and Therapeutic Medicine 20 (3), 2812-2814, 2020 | 26 | 2020 |
| Hypertension and brain damage A Coca Springer, 2016 | 22 | 2016 |
| Cardiac arrhythmias in arterial hypertension D Varvarousis, M Kallistratos, L Poulimenos, A Triantafyllis, P Tsinivizov, ... The Journal of Clinical Hypertension 22 (8), 1371-1378, 2020 | 20 | 2020 |
| Recent clinical trials in atrial fibrillation in hypertensive patients AJ Manolis, MS Kallistratos, LE Poulimenos Current hypertension reports 14, 350-359, 2012 | 20 | 2012 |
| Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European … Y Bohbot, G Habib, C Laroche, E Stöhr, C Chirouze, ... European journal of heart failure 24 (7), 1253-1265, 2022 | 16 | 2022 |
| Vasodilator β-blockers: a different class of antihypertensive agents? MS Kallistratos, LE Poulimenos, AJ Manolis Future Cardiology 10 (6), 669-671, 2014 | 15 | 2014 |
| Special issues in hypertension AE Berbari, G Mancia Springer Milan, 2012 | 14 | 2012 |
| Adverse effects of mineralocorticoid receptor antagonist administration MS Kallistratos, A Pittaras, I Theodoulidis, C Grassos, LE Poulimenos, ... Current Pharmaceutical Design 24 (46), 5537-5541, 2018 | 13 | 2018 |
